Preclinical AD Workgroup staging: pathological correlates and potential challenges.
about
The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's diseaseClinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkersClinicopathological outcomes of prospectively followed normal elderly brain bank volunteers.Mild cognitive impairment: statistical models of transition using longitudinal clinical dataUsing mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse modelsPrimary age-related tauopathy (PART): a common pathology associated with human agingIs synaptic loss a unique hallmark of Alzheimer's disease?Quantitative neuropathological assessment to investigate cerebral multi-morbidity.Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature.Are the revised diagnostic criteria for Alzheimer's disease useful in low- and middle-income countries?Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.Effect of purpose in life on the relation between Alzheimer disease pathologic changes on cognitive function in advanced ageUniversity of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.Brain pathologies in extreme old age.Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changesCorrelation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literatureSerum multivalent cationic pattern: speculation on the efficient approach for detection of Alzheimer's disease.Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.Selective alterations of neurons and circuits related to early memory loss in Alzheimer's disease.Challenges of multimorbidity of the aging brain: a critical update.Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly.Molecular and cellular pathophysiology of preclinical Alzheimer's disease."New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS).The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.Multiregional Age-Associated Reduction of Brain Neuronal Reserve Without Association With Neurofibrillary Degeneration or β-Amyloidosis.Cognitive Domain Dispersion Association with Alzheimer's Disease Pathology.
P2860
Q26991654-9C037C7E-DE36-4A1C-BB52-26744750AA73Q27008249-68209385-ABE7-47EC-92B0-08FAF03A5FC2Q33456273-3BB0A099-6198-4DB4-91EC-0E0521CCA943Q34247588-AA0579B3-9140-416B-BCD3-AC32207ABFC1Q34418781-8596B70A-5B78-48C6-B0E7-B352FCBC0DB2Q34445021-03A1E397-10B8-4E5E-9D25-A80D71B85099Q34504659-7BE2FFBF-9272-4D87-9429-D43AD4F0DEE1Q34584768-58E61776-1F37-4461-9694-38C92CE6B939Q35166684-0128009A-6EB9-4BDD-A63D-60AA6C2D00BEQ35740679-7B2C1A73-5A85-480B-9F6E-B742D673E47AQ35991723-BF65D1CC-639C-4500-BCB1-B4EF06299750Q36075510-40A9AB29-29A3-4AA1-A3F7-14C3F7696DDBQ36131008-0970B715-C938-4770-AB16-2976180ECFC1Q36395714-E5816A6B-8E9E-4C37-806D-16AD7F6FB4E0Q36438010-47EB8FD3-A085-4DAB-A0CC-34E6E6C4E0F0Q36575903-3B261CBB-76FA-4FEC-976E-29A6B0FD6E4CQ37224163-A82DDF4D-9F85-45FC-970C-ACF7704DBA2EQ37986572-8103C18E-064E-4366-8B2A-BAD5FE68B604Q38218089-99A0A378-337B-476F-8A78-73E89875D904Q38236878-42C851A1-C353-4949-A041-92C234E5E644Q38388660-A0D24CC9-525A-4089-8E77-A210EE5311EFQ38836004-532D6478-5DE2-4AC1-887F-F0B67717B2F3Q38841003-BB7CD69E-5883-4BC2-923A-C668131D103EQ46251905-73B58035-8C35-4803-8CB1-99ED5ADB51B4Q47407570-8F6A4214-D119-4C63-8E48-8122CFB630CAQ50438030-C529952D-7853-47DD-8244-D6E4E1A11554Q51825935-748FDA63-D6F0-4817-9F12-EDBAA365BD26
P2860
Preclinical AD Workgroup staging: pathological correlates and potential challenges.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Preclinical AD Workgroup staging: pathological correlates and potential challenges.
@ast
Preclinical AD Workgroup staging: pathological correlates and potential challenges.
@en
type
label
Preclinical AD Workgroup staging: pathological correlates and potential challenges.
@ast
Preclinical AD Workgroup staging: pathological correlates and potential challenges.
@en
prefLabel
Preclinical AD Workgroup staging: pathological correlates and potential challenges.
@ast
Preclinical AD Workgroup staging: pathological correlates and potential challenges.
@en
P2093
P2860
P1476
Preclinical AD Workgroup staging: pathological correlates and potential challenges
@en
P2093
Charles D Smith
Frederick A Schmitt
Gregory A Jicha
Gregory E Cooper
Kathryn P Riley
Linda J Van Eldik
Marta S Mendiondo
Nancy Stiles
Peter T Nelson
Richard J Kryscio
P2860
P304
622.e1-622.e16
P356
10.1016/J.NEUROBIOLAGING.2011.02.018
P50
P577
2011-04-19T00:00:00Z